(NASDAQ: LONA) Leonabio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 44.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 38.54%.
Leonabio's earnings in 2026 is -$37,723,000.On average, 4 Wall Street analysts forecast LONA's earnings for 2026 to be -$20,214,393, with the lowest LONA earnings forecast at -$20,020,748, and the highest LONA earnings forecast at -$20,167,066.
In 2027, LONA is forecast to generate -$1,609,106 in earnings, with the lowest earnings forecast at -$1,546,004 and the highest earnings forecast at -$1,656,433.